Related Experiment Video
Updated: Sep 26, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6
Dhanraj Deshmukh1, Jin Xu1, Xi Yang1
1Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Abstract:
The cyclin-dependent kinase inhibitor p27 (Kip1) is an important regulator of the G1/S checkpoint. It is degraded by the SCF-SKP2 complex in late G1 thereby allowing cells to progress to the S phase. Here we investigated the role of the E3 ubiquitin ligase RNF6 (Ring Finger Protein 6) in cell cycle progression in prostate cancer cells. Our data demonstrate that RNF6 can promote cell cycle progression by reducing the levels of p27. Knockdown of RNF6 led to an increase in the stability of p27 and to the arrest of cells in the G1 phase. RNF6 interacted with p27 via its KIL domain and this interaction was found to be phosphorylation independent. RNF6 enhanced ubiquitination and subsequent degradation of p27 in the early G0/G1 phase of the cell cycle. Knockdown of RNF6 expression by short hairpin RNA led to inhibition of the CDK2/Cyclin E complex thereby reducing phosphorylation of Retinoblastoma protein (Rb) and to a subsequent decrease in cell cycle progression and proliferation. Our data suggest that RNF6 acts as a negative regulator for p27kip1 leading to its proteasome-dependent degradation in the early G0/G1 phase of the cell cycle.
Insights
Ring Finger Protein 6 (RNF6) promotes cell cycle progression by degrading the cyclin-dependent kinase inhibitor p27 (Kip1) in prostate cancer cells. Inhibiting RNF6 increases p27 stability, arresting cells in G1 phase.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p27 (Kip1) is a key regulator of the G1/S cell cycle checkpoint.
- Degradation of p27 by SCF-SKP2 complex facilitates cell cycle progression.
- The role of E3 ubiquitin ligase RNF6 in prostate cancer cell cycle regulation is unexplored.
Purpose of the Study:
- To investigate the role of RNF6 in regulating cell cycle progression in prostate cancer.
- To determine the mechanism by which RNF6 affects p27 levels and stability.
- To elucidate the impact of RNF6 on cell proliferation.
Main Methods:
- Knockdown of RNF6 using short hairpin RNA (shRNA).
- Analysis of p27 protein levels and stability.
- Assessment of cell cycle phase distribution (G1 arrest).
- Investigation of RNF6-p27 interaction and ubiquitination.
- Evaluation of CDK2/Cyclin E complex activity and Rb phosphorylation.
Main Results:
- RNF6 promotes cell cycle progression by reducing p27 levels.
- RNF6 knockdown increases p27 stability and causes G1 phase arrest.
- RNF6 interacts with p27 via its KIL domain in a phosphorylation-independent manner.
- RNF6 enhances p27 ubiquitination and proteasomal degradation in early G0/G1.
- RNF6 knockdown inhibits CDK2/Cyclin E, reduces Rb phosphorylation, and decreases proliferation.
Conclusions:
- RNF6 acts as a negative regulator of p27 (Kip1).
- RNF6 facilitates proteasome-dependent degradation of p27 in early G0/G1.
- RNF6 plays a significant role in prostate cancer cell cycle progression and proliferation.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of the Unfolded Protein Response
Anaphase Promoting Complex

